Biblio

Export 1161 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
I. E. Vega, Cabrera, L. Y., Wygant, C. M., Velez-Ortiz, D., and Counts, S. E., “Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.”, J Alzheimers Dis, vol. 58, no. 4, pp. 979-992, 2017.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., “Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.”, Neurology, vol. 74, no. 3, pp. 201-9, 2010.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
M. Edsbagge, Andreasson, U., Ambarki, K., Wikkelsø, C., Eklund, A., Blennow, K., Zetterberg, H., and Tullberg, M., “Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.”, J Alzheimers Dis, vol. 58, no. 3, pp. 821-828, 2017.
S. Emrani, Lamar, M., Price, C. C., Wasserman, V., Matusz, E., Au, R., Swenson, R., Nagele, R., Heilman, K. M., and Libon, D. J., “Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.”, J Alzheimers Dis, vol. 73, no. 1, pp. 63-71, 2020.
L. A. Mohamed, Zhu, H., Mousa, Y. M., Wang, E., Qiu, W. Qiao, and Kaddoumi, A., “Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1087-1099, 2017.
E. Wang, Zhu, H., Wang, X., Gower, A., Wallack, M., Blusztajn, J. Krzysztof, Kowall, N., and Qiu, W. Qiao, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
E. Wang, Zhu, H., Wang, X., Gower, A., Wallack, M., Blusztajn, J. Krzysztof, Kowall, N., and Qiu, W. Qiao, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
E. Wang, Zhu, H., Wang, X., Gower, A., Wallack, M., Blusztajn, J. Krzysztof, Kowall, N., and Qiu, W. Qiao, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
L. M. Walden, Hu, S., Madabhushi, A., and Prescott, J. W., “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
P. F. Høilund-Carlsen, Barrio, J. R., Werner, T. J., Newberg, A., and Alavi, A., “Amyloid Hypothesis: The Emperor's New Clothes?”, J Alzheimers Dis, vol. 78, no. 4, pp. 1363-1366, 2020.
G. Rolfseng Grøntvedt, Lauridsen, C., Berge, G., White, L. R., Salvesen, Ø., Bråthen, G., and Sando, S. Botne, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
F. Piazza and Winblad, B., “Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?”, J Alzheimers Dis, vol. 52, no. 2, pp. 417-20, 2016.
E. Heuer, Jacobs, J., Du, R., Wang, S., Keifer, O. P., Cintron, A. F., Dooyema, J., Meng, Y., Zhang, X., and Walker, L. C., “Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 2, pp. 519-530, 2017.
E. Heuer, Jacobs, J., Du, R., Wang, S., Keifer, O. P., Cintron, A. F., Dooyema, J., Meng, Y., Zhang, X., and Walker, L. C., “Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 2, pp. 519-530, 2017.
S. Hatashita and Wakebe, D., “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
Y. Zhang, Guo, O., Huo, Y., Wang, G., and Man, H. - Y., “Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1789-1801, 2018.
N. Liu, Yu, Z., Xun, Y., Shu, P., Yue, Y., Yuan, S., Jiang, Y., Huang, Z., Yang, X., Feng, X., Xiang, S., and Wang, X., “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
L. - J. Zuo, Guo, P., Liu, L., Yu, S. - Y., Lian, T. - H., Yu, Q. - J., Hu, Y., Jin, Z., Wang, R. - D., Piao, Y. - S., Li, L. - X., Wang, Y. - J., Wang, X. - M., and Zhang, W., “Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction.”, J Alzheimers Dis, vol. 66, no. 2, pp. 789-799, 2018.
L. - J. Zuo, Guo, P., Liu, L., Yu, S. - Y., Lian, T. - H., Yu, Q. - J., Hu, Y., Jin, Z., Wang, R. - D., Piao, Y. - S., Li, L. - X., Wang, Y. - J., Wang, X. - M., and Zhang, W., “Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction.”, J Alzheimers Dis, vol. 66, no. 2, pp. 789-799, 2018.
L. - J. Zuo, Guo, P., Liu, L., Yu, S. - Y., Lian, T. - H., Yu, Q. - J., Hu, Y., Jin, Z., Wang, R. - D., Piao, Y. - S., Li, L. - X., Wang, Y. - J., Wang, X. - M., and Zhang, W., “Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction.”, J Alzheimers Dis, vol. 66, no. 2, pp. 789-799, 2018.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., “Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.”, J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., “Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.”, J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., “Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.”, J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.

Pages